KMVAX — Kirr, Marbach Partners Value Fund
Data updated: 2026-05-29
KMVAX — Kirr, Marbach Partners Value Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Mid Cap Growth Equity · $103.85M AUM · 1.35% expense ratio · 24.0% 1-yr return. From SEC regulatory filings.
KMVAX Fund Overview
KMVAX — Kirr, Marbach Partners Value Fund is a US mutual fund managed by Kirr Marbach Partners Funds INC, categorised as United States Mid Cap Growth Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Kirr Marbach Partners Funds INC
- Category: United States Mid Cap Growth Equity
- Assets under management: $103.85M
- 1-year return: 24.0%
- Ticker: KMVAX
- SEC CIK: 0001071196
- SEC series ID: S000009002
- Share class ID: C000024491
KMVAX Holdings
Top 10 holdings of Kirr, Marbach Partners Value Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| MasTec Inc | 9.27% |
| EMCOR Group Inc | 8.47% |
| Broadcom Inc | 5.92% |
| Alphabet Inc | 5.35% |
| Vistra Corp | 4.84% |
| AutoZone Inc | 4.59% |
| Republic Services Inc | 4.06% |
| Markel Group Inc | 3.30% |
| Colliers International Group I | 3.11% |
| Moog Inc | 3.10% |
KMVAX Portfolio Allocation
Asset-class allocation of Kirr, Marbach Partners Value Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.1% |
| Cash & Equivalents | 0.9% |
KMVAX Performance
Total returns for KMVAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 2.0% |
| 1 year | 24.0% |
| 3 years (annualised) | 19.0% |
| 5 years (annualised) | 12.0% |
KMVAX Risk Information
Risk metrics for KMVAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.2%
KMVAX Costs and Fees
KMVAX costs about $135 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.35%
- Gross expense ratio: 1.30%
- Portfolio turnover: 10%
- Brokerage commissions: 1.60 bps of average net assets (SEC N-CEN)
KMVAX Cashflows
Over the 12 months to 2026-03, Kirr, Marbach Partners Value Fund had net inflows of $3.58M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$190.14K |
| 2026-02 | $1.37M |
| 2026-01 | −$9.62M |
| 2025-12 | $4.33M |
| 2025-11 | −$43.84K |
| 2025-10 | $8.15M |
KMVAX Debt Constituents
No individual debt constituents are reported in Kirr, Marbach Partners Value Fund's latest SEC N-PORT filing.
KMVAX Prospectus and SEC Filings
Official Kirr, Marbach Partners Value Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Mid Cap Growth Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.